Patent · US Active

Radiomitigating pharmaceutical formulations

US9783515B2 · kind B2 · utility

0Cited by

2References

44Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

William McBride · Manchester, US
Ewa Micewicz · Los Angeles, US

Key dates

Filing date	May 7, 2014
Grant date	Oct 10, 2017
Priority date	—
Expiry date	May 7, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D333/34
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present disclosure relates to compounds of Formula (I) and (II), compositions containing the compounds (alone or in combination with other agents), and their use to prevent, mitigate or treat a) damage induced by ionizing radiation, b) inflammation or c) cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.